Twist Bioscience Income Statement (2017-2026) | TWST

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	35.02M	37.95M	42.02M	48.13M	56.11M	57.31M	54.24M	60.18M	63.74M	66.95M	71.50M	75.30M	81.46M	84.71M	88.71M	92.79M	96.06M	99.01M	103.70M	110.72M
Gross Profit (Quarter)	14.09M	15.45M	14.96M	18.41M	25.14M	25.72M	24.80M	18.51M	21.89M	24.52M	28.96M	30.88M	35.27M	38.23M	42.84M	46.03M	51.30M	50.84M	53.97M	57.12M
Operating items
Research & Development (Quarter)	19.84M	19.44M	22.63M	31.23M	36.84M	29.61M	31.24M	27.38M	24.53M	23.75M	23.10M	24.15M	22.47M	21.13M	21.31M	23.92M	18.05M	17.01M	17.13M	19.70M
Selling, General & Administrative (Quarter)	34.48M	38.24M	51.10M	54.00M	53.69M	54.16M	42.32M	53.97M	46.06M	47.39M	52.84M	55.62M	56.79M	53.14M	56.18M	63.67M	63.37M	63.76M	69.74M	76.08M
Restructuring Costs (Quarter)																				7.21M
Other Operating Expenses (Quarter)	-1.89M	2.42M	2.83M	6.01M	4.23M	1.17M	4.13M	1.20M	0.58M						45.87M	46.77M	48.85M	-48.85M	49.73M	53.59M
Operating Expenses (Quarter)	77.14M	77.76M	97.96M	108.93M	117.28M	114.18M	98.87M	121.82M	124.52M	117.06M	118.47M	124.19M	170.39M	120.75M	123.36M	134.35M	126.18M	128.94M	136.60M	156.58M
Operating Income (Quarter)	-42.12M	-39.81M	-55.94M	-60.80M	-61.16M	-56.87M	-44.63M	-61.64M	-60.78M	-50.11M	-46.98M	-48.89M	-88.92M	-36.04M	-34.64M	-41.56M	-30.12M	-29.93M	-32.90M	-45.86M
EBIT (Quarter)	-42.12M	-39.81M	-55.94M	-60.80M	-61.16M	-56.87M	-44.63M	-61.64M	-60.78M	-50.11M	-46.98M	-48.89M	-88.92M	-36.04M	-34.64M	-41.56M	-30.12M	-29.93M	-32.90M	-45.86M
Non-operating items
Interest & Investment Income (Quarter)	0.09M	0.06M	0.15M	0.26M	0.72M	1.93M	3.04M	3.46M	3.97M	3.89M	4.12M	3.94M	3.66M	3.62M	3.24M	2.80M	2.69M	2.63M	2.17M	1.71M
Other Non Operating Income (Quarter)	-0.31M	-1.06M	-0.16M	-0.24M	-0.23M	-0.46M	-0.16M	-0.30M	0.04M	-0.25M	-0.03M	-0.20M	-0.12M	-2.33M	-0.09M	-0.39M	-0.84M	0.42M	0.47M	0.17M
Non Operating Income (Quarter)	-0.31M	-1.06M	-0.16M	-0.24M	-0.23M	-0.46M	-0.16M	-0.30M	0.04M	-0.25M	-0.03M	-0.20M	-0.12M	-2.33M	-0.09M	-0.39M	-0.84M	0.42M	0.47M	0.17M
Net income details
EBT (Quarter)	-42.41M	-40.90M	-55.97M	-60.82M	-60.67M	-50.82M	-41.75M	-58.48M	-56.77M	-46.47M	-42.89M	-45.15M	-85.38M	-34.75M	-31.50M	-39.15M	20.58M	-26.88M	-30.25M	-43.98M
Tax Provisions (Quarter)	-2.38M	0.37M	-10.40M	-0.15M	-0.15M	0.30M	0.08M	0.70M	0.62M	-0.22M	0.12M	0.34M	0.20M	-0.10M	0.10M	0.20M	0.20M	0.24M	0.25M	0.04M
Profit After Tax (Quarter)	-40.04M	-41.24M	-45.56M	-60.67M	-60.52M	-51.15M	-41.82M	-59.16M	-57.40M	-46.24M	-43.01M	-45.49M	-85.57M	-34.63M	-31.59M	-39.33M	20.40M	-27.14M	-30.50M	-44.02M
Income from Continuing Operations (Quarter)	-40.04M	-41.27M	-45.56M	-60.67M	-60.52M	-51.13M	-41.82M	-59.18M	-57.40M	-46.24M	-43.01M	-45.49M	-85.58M	-34.65M	-31.60M	-39.35M	20.38M	-27.12M	-30.51M	-44.02M
Consolidated Net Income (Quarter)	-40.04M	-41.27M	-45.56M	-60.67M	-60.52M	-51.13M	-41.82M	-59.18M	-57.40M	-46.24M	-43.01M	-45.49M	-85.58M	-34.65M	-31.60M	-39.35M	20.38M	-27.12M	-30.51M	-44.02M
Income towards Parent Company (Quarter)	-40.04M	-41.27M	-45.56M	-60.67M	-60.52M	-51.13M	-41.82M	-59.18M	-57.40M	-46.24M	-43.01M	-45.49M	-85.58M	-34.65M	-31.60M	-39.35M	20.38M	-27.12M	-30.51M	-44.02M
Net Income towards Common Stockholders (Quarter)	-40.04M	-41.27M	-45.56M	-60.67M	-60.52M	-51.13M	-41.82M	-59.18M	-57.40M	-46.24M	-43.01M	-45.49M	-85.58M	-34.65M	-31.60M	-39.35M	20.38M	-27.12M	-30.51M	-44.02M
Additional items
EPS (Basic) (Quarter)	-0.82	-0.83	-0.91	-1.13	-1.08	-0.89	-0.74	-1.04	-1.01	-0.81	-0.75	-0.79	-1.47	-0.59	-0.53	-0.66	0.34	-0.45	-0.50	-0.71
EPS (Weighted Average and Diluted) (Quarter)	-0.82	-0.83	-0.91	-1.13	-1.08	-0.89	-0.74	-1.04	-1.01	-0.81	-0.75	-0.79	-1.47	-0.59	-0.53	-0.66	0.33	-0.45	-0.50	-0.71
Shares Outstanding (Weighted Average) (Quarter)	47.88M	48.25M	49.91M	51.67M	56.29M	53.88M	56.44M	56.78M	57.04M	56.88M	57.50M	57.78M	57.81M	58.02M	59.16M	59.40M	59.99M	59.81M	61.08M	61.39M
Shares Outstanding (Diluted Average) (Quarter)	48.96M	48.25M	49.91M	53.47M	53.01M	53.88M	56.44M	56.78M	56.75M	56.88M	57.50M	57.64M	58.15M	58.02M	59.16M	59.65M	59.60M	59.81M	61.08M	61.39M
EBITDA (Quarter)	-39.80M	-41.12M	-45.38M	-61.51M	-61.42M	-51.58M	-43.06M	-58.44M	-58.14M	-46.36M	-42.82M	-45.59M	-85.65M	-34.44M	-31.72M	-39.32M	20.19M	-26.90M	-30.45M	-44.09M
Interest Expenses (Quarter)	0.07M	0.08M	0.03M	0.03M		0.03M	0.00M	0.00M	0.00M	0.00M				0.03M	0.02M	0.14M
Shares Outstanding (Quarter)	49.26M	49.50M	50.73M	56.23M	56.34M	56.52M	56.65M	57.10M	57.37M	57.56M	57.78M	58.16M	58.52M	58.88M	59.58M	59.86M	60.17M	60.63M	61.27M	62.15M
Tax Rate (Quarter)	5.60	-0.91	18.59	0.24	0.25	-0.60	-0.18	-1.20	-1.10	0.48	-0.28	-0.76	-0.23	0.29	-0.32	-0.51	0.97	-0.89	-0.84	-0.10

Research Tools

Twist Bioscience Income Statement (2017-2026) | TWST

Create an account

Sign In

Reset Password